Showing results (71-80 of 79) with videos related to
Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
Molecular Cell|December 15, 2019
Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in MelanomaMarie R Webster, Mitchell E Fane, Gretchen M Alicea, et al.Nature|August 10, 2018
Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 responseGang Chen, Alexander C Huang, Wei Zhang, et al.The Journal of Allergy and Clinical Immunology|September 5, 2024
Hematopoietic cell transplantation for DOCK8 deficiency: Results from a prospective clinical trialAlexandra F Freeman, Corina E Gonzalez, Bonnie Yates, et al.Cancer Cell|August 30, 2024
Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cellsKevin Wang, Paulina Coutifaris, David Brocks, et al.Nature Medicine|February 27, 2019
A single dose of neoadjuvant PD-1 blockade predicts clinical outcomes in resectable melanomaAlexander C Huang, Robert J Orlowski, Xiaowei Xu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 23, 2018
Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant MelanomaGao Zhang, Lawrence W Wu, Ilgen Mender, et al.Cell Reports|June 3, 2026
Melanoma-patient-derived xenograft multi-omics resource melPDomiX maps gain- and loss-of-function alterationsKonstantinos Tsingas, Monzy Thomas, McKenna Reale, et al.JCO Precision Oncology|April 5, 2024
Repeat Next-Generation Sequencing Testing on Progression in Men With Metastatic Prostate Cancer Can Identify New Actionable AlterationsJoseph J Park, Alec Chu, Jinju Li, et al.Cancer Research|August 31, 2021
Neural Crest-Like Stem Cell Transcriptome Analysis Identifies LPAR1 in Melanoma Progression and Therapy ResistanceJianglan Liu, Vito W Rebecca, Andrew V Kossenkov, et al.Pageof 8